| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 41.352 | 253.236 | 311.869 | 378.933 |
| Total Income - EUR | - | - | - | - | - | - | 41.353 | 253.237 | 311.914 | 378.935 |
| Total Expenses - EUR | - | - | - | - | - | - | 26.180 | 138.204 | 195.330 | 230.382 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 15.173 | 115.033 | 116.583 | 148.553 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 14.767 | 112.551 | 113.527 | 125.218 |
| Employees | - | - | - | - | - | - | 2 | 3 | 4 | 4 |
Check the financial reports for the company - Pure Eye Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 37 | 28.050 | 126.950 | 121.274 |
| Current Assets | - | - | - | - | - | - | 16.556 | 118.390 | 68.620 | 88.225 |
| Inventories | - | - | - | - | - | - | 5.660 | 11.300 | 13.354 | 13.297 |
| Receivables | - | - | - | - | - | - | 2.766 | 103.196 | 41.901 | 29.994 |
| Cash | - | - | - | - | - | - | 8.129 | 3.894 | 13.366 | 44.934 |
| Shareholders Funds | - | - | - | - | - | - | 13.925 | 112.600 | 113.575 | 125.267 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 2.668 | 33.839 | 81.994 | 84.232 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pure Eye Med S.r.l.